@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
  @prefix doi: <https://doi.org/> .
  @prefix event: <http://purl.org/NET/c4dm/event.owl#> .
  @prefix dc: <http://purl.org/dc/elements/1.1/> .
  @prefix epid: <https://arxiv.universalpublishings.com/id/> .
  @prefix geo: <http://www.w3.org/2003/01/geo/wgs84_pos#> .
  @prefix eprel: <http://eprints.org/relation/> .
  @prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
  @prefix ep: <http://eprints.org/ontology/> .
  @prefix dct: <http://purl.org/dc/terms/> .
  @prefix void: <http://rdfs.org/ns/void#> .
  @prefix foaf: <http://xmlns.com/foaf/0.1/> .
  @prefix skos: <http://www.w3.org/2004/02/skos/core#> .
  @prefix bibo: <http://purl.org/ontology/bibo/> .
  @prefix owl: <http://www.w3.org/2002/07/owl#> .
  @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
  @prefix cc: <http://creativecommons.org/ns#> .

<>
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/63144>;
	rdfs:comment "The repository administrator has not yet configured an RDF license."^^xsd:string .

<https://arxiv.universalpublishings.com/id/eprint/63144#authors>
	rdf:_1 <https://arxiv.universalpublishings.com/id/person/ext-241c1ec4ce2cc67c32acdbf31c562519> .

<https://arxiv.universalpublishings.com/id/eprint/63144/>
	dc:format "text/html";
	dc:title "HTML Summary of #63144 \n\nCLINICAL PHARMACOLOGY OF BETA 2 ADRENOMIMETIC DRUGS\n\n";
	foaf:primaryTopic <https://arxiv.universalpublishings.com/id/eprint/63144> .

<https://arxiv.universalpublishings.com/id/eprint/63144>
	bibo:abstract "Beta-2 adrenomimetic drugs, also known as beta-2 adrenergic agonists, represent one of the most important pharmacological groups used in respiratory and obstetric medicine. They act selectively on beta-2 adrenergic receptors, producing smooth muscle relaxation, bronchodilation, and inhibition of uterine contractions. These agents are crucial in the management of asthma, chronic obstructive pulmonary disease (COPD), and premature labor. However, their use requires careful consideration of pharmacokinetics, receptor selectivity, and adverse effects, particularly in patients with cardiovascular disease, diabetes, or thyroid dysfunction. This article provides an in-depth overview of the pharmacodynamics, pharmacokinetics, clinical applications, adverse reactions, and therapeutic nuances of beta-2 adrenomimetic drugs, emphasizing their role in modern clinical pharmacology and rational drug therapy."^^xsd:string;
	bibo:authorList <https://arxiv.universalpublishings.com/id/eprint/63144#authors>;
	bibo:status <http://purl.org/ontology/bibo/status/published>;
	dct:creator <https://arxiv.universalpublishings.com/id/person/ext-241c1ec4ce2cc67c32acdbf31c562519>;
	dct:date "2025-10-29";
	dct:isPartOf <https://arxiv.universalpublishings.com/id/repository>,
		<https://arxiv.universalpublishings.com/id/publication/ext-d62a5dbdabc792c15cf76756361a4d36>;
	dct:publisher <https://arxiv.universalpublishings.com/id/org/ext-20ef1f289b7920027328009b5eefe52c>;
	dct:title "CLINICAL PHARMACOLOGY OF BETA 2 ADRENOMIMETIC DRUGS"^^xsd:string;
	rdf:type bibo:AcademicArticle,
		bibo:Article,
		ep:ArticleEPrint,
		ep:EPrint;
	rdfs:seeAlso <https://arxiv.universalpublishings.com/id/eprint/63144/> .

<https://arxiv.universalpublishings.com/id/org/ext-20ef1f289b7920027328009b5eefe52c>
	foaf:name "Center for Tech and Media Research"^^xsd:string;
	rdf:type foaf:Organization .

<https://arxiv.universalpublishings.com/id/person/ext-241c1ec4ce2cc67c32acdbf31c562519>
	foaf:familyName "Guzaloy"^^xsd:string;
	foaf:givenName "Numonova"^^xsd:string;
	foaf:name "Numonova Guzaloy"^^xsd:string;
	rdf:type foaf:Person .

<https://arxiv.universalpublishings.com/id/publication/ext-d62a5dbdabc792c15cf76756361a4d36>
	foaf:name "Multidisciplinary Journal of Science and Technology"^^xsd:string;
	rdf:type bibo:Collection .